Eli Lilly and Company
Selective estrogen receptor degraders

Abstract:

Novel selective estrogen receptor degraders (SERDs) according to the formula: ##STR00001## pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, wherein either R.sup.1 or R.sup.2 is independently selected from Cl, F, --CF.sub.3, or --CH.sub.3, and the other is hydrogen, and methods for their use are provided.